Search research articles
Contact Us
Filters
Showing results (51-60 of 54) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 54 results.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports
|
February 8, 2003
Core functions and capabilities of state public health laboratories: a report of the Association of Public Health Laboratories
Joyce Witt-Kushner, J Rex Astles, John C Ridderhof, et al.
Medical Mycology
|
February 24, 2001
Pathogenesis I: interactions of host cells and fungi
K V Clemons, V L Calich, E Burger, et al.
Journal of Clinical Microbiology
|
March 31, 2012
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution
M A Pfaller, A Espinel-Ingroff, E Canton, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2021
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor
Brendan D Curti, Yoshinobu Koguchi, Rom S Leidner, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 54) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 54 results.
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports
|
February 8, 2003
Core functions and capabilities of state public health laboratories: a report of the Association of Public Health Laboratories
Joyce Witt-Kushner, J Rex Astles, John C Ridderhof, et al.
Medical Mycology
|
February 24, 2001
Pathogenesis I: interactions of host cells and fungi
K V Clemons, V L Calich, E Burger, et al.
Journal of Clinical Microbiology
|
March 31, 2012
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution
M A Pfaller, A Espinel-Ingroff, E Canton, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2021
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor
Brendan D Curti, Yoshinobu Koguchi, Rom S Leidner, et al.
Page
of 6